Management of relapsing disease in prostate cancer
- 1 July 1992
- Vol. 70 (S1) , 329-334
- https://doi.org/10.1002/1097-0142(19920701)70:1+<329::aid-cncr2820701322>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Octreotide and Bromocriptine in patients with stage D2 prostate cancer who relapsed during treatment with flutamide and castrationEuropean Journal of Cancer and Clinical Oncology, 1990
- Suramin for prostatic cancer: A phase I/II study in advanced extensively pretreated diseaseEuropean Journal of Cancer and Clinical Oncology, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Objective Responses to Ketoconazole Therapy in Patients with Relapsed Progressive Prostatic CancerBritish Journal of Urology, 1986
- Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survivalJournal of Steroid Biochemistry, 1985
- Flutamide Therapy for Advanced Prostatic Cancer: a Phase II StudyBritish Journal of Urology, 1985
- The Diagnosis of Oestrogen Escape and the Role of Secondary Orchiectomy in Prostatic CancerBritish Journal of Urology, 1980
- Adrenal Suppression in the Treatment of Carcinoma of the ProstateBritish Journal of Urology, 1974
- Current Status of Bilateral Adrenalectomy or Advanced Prostatic CarcinomaAnnals of Surgery, 1974
- A survey of total adrenalectomy in cancer of the prostateThe American Journal of Surgery, 1960